Lin Zhang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Prognostic Factors

Top Venues

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Huixian Miao, Huangyang Meng, Yashuang Zhang, Tian Chen, Lin Zhang, Wenjun Cheng
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell death and differentiation (2024)
Huixian Miao, Huangyang Meng, Yashuang Zhang, Tian Chen, Lin Zhang, Wenjun Cheng
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell death and differentiation 31 (4) (2024)
Huixian Miao, Huangyang Meng, Yashuang Zhang, Tian Chen, Lin Zhang, Wenjun Cheng
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell death and differentiation 31 (4) (2024)
Huixian Miao, Huangyang Meng, Yashuang Zhang, Tian Chen, Lin Zhang, Wenjun Cheng
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell death and differentiation 31 (4) (2024)